These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 32822087)

  • 61. Review: Sporadic Parkinson's disease: development and distribution of α-synuclein pathology.
    Del Tredici K; Braak H
    Neuropathol Appl Neurobiol; 2016 Feb; 42(1):33-50. PubMed ID: 26662475
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Can the gut be the missing piece in uncovering PD pathogenesis?
    Chapelet G; Leclair-Visonneau L; Clairembault T; Neunlist M; Derkinderen P
    Parkinsonism Relat Disord; 2019 Feb; 59():26-31. PubMed ID: 30448099
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Gut and Nonmotor Symptoms in Parkinson's Disease.
    Klingelhoefer L; Reichmann H
    Int Rev Neurobiol; 2017; 134():787-809. PubMed ID: 28805583
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [When germs get involved in Parkinson's disease].
    Khenniche Y; Lutete E; Bobé P
    Med Sci (Paris); 2017 Nov; 33(11):950-953. PubMed ID: 29200392
    [No Abstract]   [Full Text] [Related]  

  • 65. SARS-CoV-2-Mimicking Pseudoviral Particles Accelerate α-Synuclein Aggregation In Vitro.
    Zilio G; Masato A; Sandre M; Caregnato A; Moret F; Maciola AK; Antonini A; Brucale M; Cendron L; Plotegher N; Bubacco L
    ACS Chem Neurosci; 2024 Jan; 15(2):215-221. PubMed ID: 38131609
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gut dysbiosis and long COVID-19: Feeling gutted.
    Giannos P; Prokopidis K
    J Med Virol; 2022 Jul; 94(7):2917-2918. PubMed ID: 35233795
    [No Abstract]   [Full Text] [Related]  

  • 67. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease.
    Van der Perren A; Macchi F; Toelen J; Carlon MS; Maris M; de Loor H; Kuypers DR; Gijsbers R; Van den Haute C; Debyser Z; Baekelandt V
    Neurobiol Aging; 2015 Mar; 36(3):1559-68. PubMed ID: 25660193
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.
    Barrenschee M; Zorenkov D; Böttner M; Lange C; Cossais F; Scharf AB; Deuschl G; Schneider SA; Ellrichmann M; Fritscher-Ravens A; Wedel T
    Acta Neuropathol Commun; 2017 Jan; 5(1):1. PubMed ID: 28057070
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system.
    Noorian AR; Rha J; Annerino DM; Bernhard D; Taylor GM; Greene JG
    Neurobiol Dis; 2012 Oct; 48(1):9-19. PubMed ID: 22722052
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease.
    Galvagnion C
    J Parkinsons Dis; 2017; 7(3):433-450. PubMed ID: 28671142
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Impact of COVID-19 on Access to Parkinson's Disease Medication.
    Cheong JL; Goh ZHK; Marras C; Tanner CM; Kasten M; Noyce AJ;
    Mov Disord; 2020 Dec; 35(12):2129-2133. PubMed ID: 32860226
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19.
    Mancini M; Natoli S; Gardoni F; Di Luca M; Pisani A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982693
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope?
    Lau HC; Ng SC; Yu J
    Gastroenterology; 2022 Jan; 162(1):9-16. PubMed ID: 34508775
    [No Abstract]   [Full Text] [Related]  

  • 74. What is the Evidence That Parkinson's Disease is a Prion Disorder, Which Originates in the Gut?
    Kujawska M; Jodynis-Liebert J
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424585
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intragastric proteasome inhibition induces alpha-synuclein-immunopositive aggregations in neurons in the dorsal motor nucleus of the vagus in rats.
    Miwa H; Kubo T; Suzuki A; Kondo T
    Neurosci Lett; 2006 Jun; 401(1-2):146-9. PubMed ID: 16600504
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats.
    Holmqvist S; Chutna O; Bousset L; Aldrin-Kirk P; Li W; Björklund T; Wang ZY; Roybon L; Melki R; Li JY
    Acta Neuropathol; 2014 Dec; 128(6):805-20. PubMed ID: 25296989
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Modification of the gut microbiome to combat neurodegeneration.
    Sasmita AO
    Rev Neurosci; 2019 Nov; 30(8):795-805. PubMed ID: 31095511
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Heterogeneity in gut microbiota drive polyphenol metabolism that influences α-synuclein misfolding and toxicity.
    Ho L; Zhao D; Ono K; Ruan K; Mogno I; Tsuji M; Carry E; Brathwaite J; Sims S; Frolinger T; Westfall S; Mazzola P; Wu Q; Hao K; Lloyd TE; Simon JE; Faith J; Pasinetti GM
    J Nutr Biochem; 2019 Feb; 64():170-181. PubMed ID: 30530257
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Parkinson's disease: 4 big questions.
    Deweerdt S
    Nature; 2016 Oct; 538(7626):S17. PubMed ID: 27783579
    [No Abstract]   [Full Text] [Related]  

  • 80. miR-let-7a suppresses α-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease.
    Zhang J; Dongwei Zhou ; Zhang Z; Xinhui Qu ; Kunwang Bao ; Guohui Lu ; Jian Duan
    Biochem Biophys Res Commun; 2019 Nov; 519(4):740-746. PubMed ID: 31547989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.